Proskauer advised Bausch Health Companies Inc. on the transaction. Bausch Health Companies Inc. (NYSE: BHC) (TSX: BHC) (“Bausch Health”) announced its $7.9 billion refinancing transaction, which...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here